Global Filters




Tiers


Species


Attribution

Filter by Tier
Filter by Species
Filter by Attributions
like "mouse, Ap3m2, alcohol"

Search results are limited to 1000 results out of 1409. Try refining your search.

Returning 1000 results: Page 1 of 40


Tier Species Size Attr. GeneSet
Tier I 26 GS270003: GWAS Catalog Data for type I diabetes mellitus in 9,934 European ancestry cases, 16,956 European ancestry controls
Tier I 10 GS270919: GWAS Catalog Data for body mass index in 22,762 East Asian ancestry individuals, 2,522 Malay ancestry individuals, 2,431 Chinese, Malay and Asian Indian ancestry individuals
Tier I 84 GS230702: MSigDB Geneset - chr2p23
Tier IV 9412 GS404756: Up regulated genes from caudate nucleus (from dorsal striatum) from postmortem human brain tissue with Alcohol Use Disorder (AUD)
Tier IV 8406 GS404762: Up regulated genes from ventral striatum from postmortem human brain tissue with Alcohol Use Disorder (AUD)
Tier IV 18653 GS407376: Dysregulation of NRSF/REST via EHMT1 is associated with psychiatric disorders and Kleefstra syndrome
Tier IV 12707 GS407573: Differentially expressed genes from Normal Retina Pigment Epithelium (RPE) compared to Normal Retina tissue in Age Related Macular Degeneration (AMD) patients
Tier III 19901 GS407933: Differentially expressed genes of post mortem human central Amygdala samples in patients affected by opioid use disorder (OUD) vs. unaffected control samples_Log2FC
Tier III 19901 GS407934: Differentially expressed genes of post mortem human central Amygdala samples in patients affected by opioid use disorder (OUD) vs. unaffected control samples_qvalue
Tier III 17086 GS407944: Differentially expressed genes in opioid use disorder postmortem human brain_qvalue
Tier III 17086 GS407945: Differentially expressed genes in opioid use disorder postmortem human brain_log2FC
Tier III 18513 GS407948: Differentially expressed genes in humans nucleus accumbens associated with opioid use disorder_log2FC
Tier III 18278 GS407950: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_log2FC
Tier III 18278 GS407951: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_qvalue
Tier III 19863 GS407964: Differential gene expression in human postmortem tissue samples of the dorsolateral prefrontal cortex_logFC
Tier III 19863 GS407965: Differential gene expression in human postmortem tissue samples of the dorsolateral prefrontal cortex_qvalue
Tier IV 9363 GS408182: Differential gene expression comparison between Carnegie Stages (CS) 15 and 22 during human embryo craniofacial development, log2FC
Tier IV 9363 GS408183: Differential gene expression comparison between Carnegie Stages (CS) 15 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 10391 GS408184: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, log2FC
Tier IV 10391 GS408185: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 9299 GS408186: Differential gene expression comparison between Carnegie Stages (CS) 17 and 22 during human embryo craniofacial development, log2FC
Tier IV 9299 GS408188: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 10134 GS408189: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, log2FC
Tier IV 10134 GS408190: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 13854 GS408212: Transcriptional differences in dorsolateral prefrontal cortex (DLPFC) and nucleus accumbens (NAc) in unaffected comparison subjects_coefficient